Genetic Deficiency in Neprilysin or Its Pharmacological Inhibition Initiate Excessive Stress-Induced Alcohol Consumption in Mice
Open Access
- 21 November 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (11) , e50187
Abstract
Both acquired and inherited genetic factors contribute to excessive alcohol consumption and the corresponding development of addiction. Here we show that the genetic deficiency in neprilysin [NEP] did not change the kinetics of alcohol degradation but led to an increase in alcohol intake in mice in a 2-bottle-free-choice paradigm after one single stress stimulus (intruder). A repetition of such stress led to an irreversible elevated alcohol consumption. This phenomenon could be also observed in wild-type mice receiving an orally active NEP inhibitor. We therefore elucidated the stress behavior in NEP-deficient mice. In an Elevated Plus Maze, NEP knockouts crossed more often the area between the arms, implicating a significant stronger stress response. Furthermore, such animals showed a decreased locomotor activity under intense light in a locomotor activity test, identifying such mice to be more responsive in aversive situations than their wild-type controls. Since the reduction in NEP activity itself does not lead to significant signs of an altered alcohol preference in mice but requires an environmental stimulus, our findings build a bridge between stress components and genetic factors in the development of alcoholism. Therefore, targeting NEP activity might be a very attractive approach for the treatment of alcohol abuse in a society with increasing social and financial stress.Keywords
This publication has 28 references indexed in Scilit:
- Fatty acid–induced gut-brain signaling attenuates neural and behavioral effects of sad emotion in humansJournal of Clinical Investigation, 2011
- New Function for an Old Enzyme: NEP Deficient Mice Develop Late-Onset ObesityPLOS ONE, 2010
- Blood-pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: a randomised, double-blind, placebo-controlled, active comparator studyThe Lancet, 2010
- Improved Learning and Memory in Aged Mice Deficient in Amyloid β-Degrading Neutral EndopeptidasePLOS ONE, 2009
- The Clinical Applications of a Systems ApproachPLOS Medicine, 2006
- Alcohol consumption is controlled by angiotensin IIThe FASEB Journal, 2001
- The Therapeutic Potential of Candoxatril, a Neutral Endopeptidase Inhibitor, in HumansCardiovascular Drug Reviews, 2000
- Locomotor response to an open field during C57BL/6J active and inactive phasesPhysiology & Behavior, 2000
- Formation and pharmacokinetics of the active drug candoxatrilat in mouse, rat, rabbit, dog and man following administration of the prodrug candoxatrilXenobiotica, 1997
- A review of the validity and variability of the Elevated Plus-Maze as an animal model of anxietyPharmacology Biochemistry and Behavior, 1996